Wilson Sonsini Goodrich & Rosati advised Nvelop Therapeutics on intellectual property matters related to the transaction. Chroma Medicine and Nvelop Therapeutics announced their merger and subsequent...
Nvelop Therapeutics’ Merger with Chroma
Cyclo Therapeutics’ Acquisition of Applied Molecular Transport
Fox Rothschild LLP is acting as legal advisor to Cyclo Therapeutics and Wilson Sonsini Goodrich & Rosati, P.C. is acting as legal advisor to Applied Molecular...
L Catterton’s $680 Million Acquisition of Thorne HealthTech
Kirkland & Ellis LLP is representing L Catterton, and Wilson Sonsini Goodrich & Rosati is representing Thorne HealthTech, Inc. in the transaction. Thorne HealthTech, Inc. (“Thorne”)...
Applied Molecular Transport’s $105 Million Public Offering
Wilson Sonsini Goodrich & Rosati advised Applied Molecular Transport on the deal. Applied Molecular Transport (AMT), a clinical-stage biopharmaceutical company leveraging its proprietary technology platform to...